2023-06-012024-05-312024-05-31false12632649ED ROWE MEDICAL LIMITED2024-09-0286210iso4217:GBPxbrli:pure126326492023-06-01126326492024-05-31126326492023-06-012024-05-31126326492022-06-01126326492023-05-31126326492022-06-012023-05-3112632649bus:SmallEntities2023-06-012024-05-3112632649bus:AuditExempt-NoAccountantsReport2023-06-012024-05-3112632649bus:FullAccounts2023-06-012024-05-3112632649bus:PrivateLimitedCompanyLtd2023-06-012024-05-3112632649core:WithinOneYear2024-05-3112632649core:AfterOneYear2024-05-3112632649core:WithinOneYear2023-05-3112632649core:AfterOneYear2023-05-3112632649core:ShareCapital2024-05-3112632649core:SharePremium2024-05-3112632649core:RevaluationReserve2024-05-3112632649core:OtherReservesSubtotal2024-05-3112632649core:RetainedEarningsAccumulatedLosses2024-05-3112632649core:ShareCapital2023-05-3112632649core:SharePremium2023-05-3112632649core:RevaluationReserve2023-05-3112632649core:OtherReservesSubtotal2023-05-3112632649core:RetainedEarningsAccumulatedLosses2023-05-3112632649core:LandBuildings2024-05-3112632649core:PlantMachinery2024-05-3112632649core:Vehicles2024-05-3112632649core:FurnitureFittings2024-05-3112632649core:OfficeEquipment2024-05-3112632649core:NetGoodwill2024-05-3112632649core:IntangibleAssetsOtherThanGoodwill2024-05-3112632649core:ListedExchangeTraded2024-05-3112632649core:UnlistedNon-exchangeTraded2024-05-3112632649core:LandBuildings2023-05-3112632649core:PlantMachinery2023-05-3112632649core:Vehicles2023-05-3112632649core:FurnitureFittings2023-05-3112632649core:OfficeEquipment2023-05-3112632649core:NetGoodwill2023-05-3112632649core:IntangibleAssetsOtherThanGoodwill2023-05-3112632649core:ListedExchangeTraded2023-05-3112632649core:UnlistedNon-exchangeTraded2023-05-3112632649core:LandBuildings2023-06-012024-05-3112632649core:PlantMachinery2023-06-012024-05-3112632649core:Vehicles2023-06-012024-05-3112632649core:FurnitureFittings2023-06-012024-05-3112632649core:OfficeEquipment2023-06-012024-05-3112632649core:NetGoodwill2023-06-012024-05-3112632649core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3112632649core:ListedExchangeTraded2023-06-012024-05-3112632649core:UnlistedNon-exchangeTraded2023-06-012024-05-3112632649core:MoreThanFiveYears2023-06-012024-05-3112632649core:Non-currentFinancialInstruments2024-05-3112632649core:Non-currentFinancialInstruments2023-05-3112632649dpl:CostSales2023-06-012024-05-3112632649dpl:DistributionCosts2023-06-012024-05-3112632649core:LandBuildings2023-06-012024-05-3112632649core:PlantMachinery2023-06-012024-05-3112632649core:Vehicles2023-06-012024-05-3112632649core:FurnitureFittings2023-06-012024-05-3112632649core:OfficeEquipment2023-06-012024-05-3112632649dpl:AdministrativeExpenses2023-06-012024-05-3112632649core:NetGoodwill2023-06-012024-05-3112632649core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3112632649dpl:GroupUndertakings2023-06-012024-05-3112632649dpl:ParticipatingInterests2023-06-012024-05-3112632649dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-05-3112632649core:ListedExchangeTraded2023-06-012024-05-3112632649dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-05-3112632649core:UnlistedNon-exchangeTraded2023-06-012024-05-3112632649dpl:CostSales2022-06-012023-05-3112632649dpl:DistributionCosts2022-06-012023-05-3112632649core:LandBuildings2022-06-012023-05-3112632649core:PlantMachinery2022-06-012023-05-3112632649core:Vehicles2022-06-012023-05-3112632649core:FurnitureFittings2022-06-012023-05-3112632649core:OfficeEquipment2022-06-012023-05-3112632649dpl:AdministrativeExpenses2022-06-012023-05-3112632649core:NetGoodwill2022-06-012023-05-3112632649core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3112632649dpl:GroupUndertakings2022-06-012023-05-3112632649dpl:ParticipatingInterests2022-06-012023-05-3112632649dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-012023-05-3112632649core:ListedExchangeTraded2022-06-012023-05-3112632649dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-012023-05-3112632649core:UnlistedNon-exchangeTraded2022-06-012023-05-3112632649core:NetGoodwill2024-05-3112632649core:IntangibleAssetsOtherThanGoodwill2024-05-3112632649core:LandBuildings2024-05-3112632649core:PlantMachinery2024-05-3112632649core:Vehicles2024-05-3112632649core:FurnitureFittings2024-05-3112632649core:OfficeEquipment2024-05-3112632649core:AfterOneYear2024-05-3112632649core:WithinOneYear2024-05-3112632649core:ListedExchangeTraded2024-05-3112632649core:UnlistedNon-exchangeTraded2024-05-3112632649core:ShareCapital2024-05-3112632649core:SharePremium2024-05-3112632649core:RevaluationReserve2024-05-3112632649core:OtherReservesSubtotal2024-05-3112632649core:RetainedEarningsAccumulatedLosses2024-05-3112632649core:NetGoodwill2023-05-3112632649core:IntangibleAssetsOtherThanGoodwill2023-05-3112632649core:LandBuildings2023-05-3112632649core:PlantMachinery2023-05-3112632649core:Vehicles2023-05-3112632649core:FurnitureFittings2023-05-3112632649core:OfficeEquipment2023-05-3112632649core:AfterOneYear2023-05-3112632649core:WithinOneYear2023-05-3112632649core:ListedExchangeTraded2023-05-3112632649core:UnlistedNon-exchangeTraded2023-05-3112632649core:ShareCapital2023-05-3112632649core:SharePremium2023-05-3112632649core:RevaluationReserve2023-05-3112632649core:OtherReservesSubtotal2023-05-3112632649core:RetainedEarningsAccumulatedLosses2023-05-3112632649core:NetGoodwill2022-06-0112632649core:IntangibleAssetsOtherThanGoodwill2022-06-0112632649core:LandBuildings2022-06-0112632649core:PlantMachinery2022-06-0112632649core:Vehicles2022-06-0112632649core:FurnitureFittings2022-06-0112632649core:OfficeEquipment2022-06-0112632649core:AfterOneYear2022-06-0112632649core:WithinOneYear2022-06-0112632649core:ListedExchangeTraded2022-06-0112632649core:UnlistedNon-exchangeTraded2022-06-0112632649core:ShareCapital2022-06-0112632649core:SharePremium2022-06-0112632649core:RevaluationReserve2022-06-0112632649core:OtherReservesSubtotal2022-06-0112632649core:RetainedEarningsAccumulatedLosses2022-06-0112632649core:AfterOneYear2023-06-012024-05-3112632649core:WithinOneYear2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:CostValuation2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3112632649core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3112632649core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3112632649core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3112632649core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3112632649core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3112632649core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3112632649core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3112632649core:Non-currentFinancialInstrumentscore:CostValuation2023-05-3112632649core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-3112632649core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-3112632649core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-3112632649core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-3112632649core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-3112632649core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-3112632649bus:Director12023-06-012024-05-31

ED ROWE MEDICAL LIMITED

Registered Number
12632649
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2024

ED ROWE MEDICAL LIMITED
Company Information
for the year from 1 June 2023 to 31 May 2024

Director

ROWE, Edward William, Dr

Registered Address

Building 2a, D Site Kemble Airfield
Kemble
Cirencester
GL7 6BA

Registered Number

12632649 (England and Wales)
ED ROWE MEDICAL LIMITED
Balance Sheet as at
31 May 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets35573
5573
Current assets
Debtors3,57924,972
Cash at bank and on hand710,744476,799
714,323501,771
Creditors amounts falling due within one year4(81,796)(60,405)
Net current assets (liabilities)632,527441,366
Total assets less current liabilities632,582441,439
Creditors amounts falling due after one year5(16,162)(38,714)
Net assets616,420402,725
Capital and reserves
Profit and loss account616,420402,725
Shareholders' funds616,420402,725
The financial statements were approved and authorised for issue by the Director on 2 September 2024, and are signed on its behalf by:
ROWE, Edward William, Dr
Director
Registered Company No. 12632649
ED ROWE MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 31 May 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 June 23173173
At 31 May 24173173
Depreciation and impairment
At 01 June 23100100
Charge for year1818
At 31 May 24118118
Net book value
At 31 May 245555
At 31 May 237373
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security76,23854,847
Accrued liabilities and deferred income5,5585,558
Total81,79660,405
5.Creditors: amounts due after one year

2024

2023

££
Other creditors16,16238,714
Total16,16238,714